Home

Kleiner Perkins Caufield & Byers XV, LLC

CIK 1547840 · last filed 2020-10-20

Kleiner Perkins Caufield & Byers XV, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for RAPT, was dated Oct 20, 2020. Current disclosed insider exposure totals $30.3K across reported positions. The firm reports its address in Menlo Park, CA. 9 SEC filings were submitted jointly with KPCB XV Associates, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$30.3K

Companies

2

Total Filings

3

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
2750 SAND HILL ROAD
MENLO PARK, CA 94025
Phone
(650) 233-2750
State of Incorporation
DE
Related Filers
KPCB XV Associates, LLC — 9 joint filings, latest 2020-10-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RAPT Therapeutics, Inc. (RAPT) Delisted 10%+ Owner 243,383 $58.01 $14.12M $0 2 2020-10-20
ATRA 10%+ Owner 3,105 $9.76 $30.3K $0 1 2014-10-23

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-10-20 RAPT Therapeutics, Inc. (RAPT) Delisted Other (J) −1,950,000 $0 EDGAR
2020-07-16 RAPT Therapeutics, Inc. (RAPT) Delisted Other (J) −900,000 $0 EDGAR
2014-10-23 ATRA Conv (C) +5,722,260 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.